14.99
+0.13
+(0.87%)
At close: April 15 at 4:00:01 PM EDT
15.59
+0.60
+(4.00%)
Pre-Market: 4:01:07 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 65,380 | 9 |
| Sales | 38,830 | 10 |
| Net Shares Purchased (Sold) | 26,550 | 19 |
| Total Insider Shares Held | 765.56k | -- |
| % Net Shares Purchased (Sold) | 3.60% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| KIHARA JAMES Officer | Sale at price 14.82 per share. | Direct | 15,235 | Apr 8, 2025 |
| SCHNEYER MARK C. Chief Financial Officer | Sale at price 14.82 per share. | Direct | 40,133 | Apr 8, 2025 |
| KIHARA JAMES Officer | -- | Direct | -- | Apr 4, 2025 |
| SCHNEYER MARK C. Chief Financial Officer | -- | Direct | -- | Apr 4, 2025 |
| KIHARA JAMES Officer | Sale at price 17.05 per share. | Direct | 18,670 | Mar 26, 2025 |
| SCHNEYER MARK C. Chief Financial Officer | Sale at price 17.05 per share. | Direct | 54,066 | Mar 26, 2025 |
| KIHARA JAMES Officer | -- | Direct | -- | Mar 25, 2025 |
| SCHNEYER MARK C. Chief Financial Officer | -- | Direct | -- | Mar 25, 2025 |
| GAROFALO ELIZABETH A. Director | Sale at price 18.23 per share. | Direct | 89,673 | Mar 5, 2025 |
| KIHARA JAMES Officer | Sale at price 19.96 per share. | Direct | 9,481 | Feb 24, 2025 |
| SCHNEYER MARK C. Chief Financial Officer | Sale at price 19.96 per share. | Direct | 15,429 | Feb 24, 2025 |
| KIHARA JAMES Officer | -- | Direct | -- | Feb 21, 2025 |
| SCHNEYER MARK C. Chief Financial Officer | -- | Direct | -- | Feb 21, 2025 |
| KIHARA JAMES Officer | Sale at price 16.81 per share. | Direct | 68,467 | Nov 19, 2024 |
| TEEHAN BRENDAN Chief Operating Officer | Sale at price 16.81 per share. | Direct | 173,630 | Nov 19, 2024 |
| SCHNEYER MARK C. Chief Financial Officer | Sale at price 16.81 per share. | Direct | 172,454 | Nov 19, 2024 |
| KIHARA JAMES Officer | -- | Direct | -- | Nov 15, 2024 |
| TEEHAN BRENDAN Chief Operating Officer | -- | Direct | -- | Nov 15, 2024 |
| SCHNEYER MARK C. Chief Financial Officer | -- | Direct | -- | Nov 15, 2024 |
| NDU ADORA Director | -- | Direct | -- | Oct 11, 2024 |
| DAVIS STEPHEN R Chief Executive Officer | Sale at price 15.28 per share. | Direct | 485,094 | Aug 19, 2024 |
| TEEHAN BRENDAN Chief Operating Officer | Sale at price 15.28 per share. | Direct | 145,680 | Aug 19, 2024 |
| SCHNEYER MARK C. Chief Financial Officer | Sale at price 15.28 per share. | Direct | 148,720 | Aug 19, 2024 |
| DAVIS STEPHEN R Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 16, 2024 |
| TEEHAN BRENDAN Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 16, 2024 |
| SCHNEYER MARK C. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 16, 2024 |
| SCHNEYER MARK C. Chief Financial Officer | Sale at price 14.79 per share. | Direct | 14,420 | Jun 10, 2024 |
| SCHNEYER MARK C. Chief Financial Officer | -- | Direct | -- | Jun 7, 2024 |
| BREGE LAURA A Director | -- | Direct | -- | May 29, 2024 |
| HARRIGAN EDMUND P. M.D. Director | -- | Direct | -- | May 29, 2024 |
| SOLAND DANIEL B Director | -- | Direct | -- | May 29, 2024 |
| BAKER BROTHERS LIFE SCIENCES L P Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | May 29, 2024 |
| DALY JAMES M. Director | -- | Direct | -- | May 29, 2024 |
| GAROFALO ELIZABETH A. Director | -- | Direct | -- | May 29, 2024 |
| NDU ADORA Director | -- | Direct | -- | May 29, 2024 |
| DAVIS STEPHEN R Chief Executive Officer | Sale at price 16.94 per share. | Direct | 193,573 | May 2, 2024 |
| KIHARA JAMES Officer | Sale at price 16.94 per share. | Direct | 22,462 | May 2, 2024 |
| TEEHAN BRENDAN Chief Operating Officer | Sale at price 16.94 per share. | Direct | 58,900 | May 2, 2024 |
| SCHNEYER MARK C. Chief Financial Officer | Sale at price 16.94 per share. | Direct | 59,341 | May 2, 2024 |
| DAVIS STEPHEN R Chief Executive Officer | -- | Direct | -- | May 1, 2024 |
| KIHARA JAMES Officer | -- | Direct | -- | May 1, 2024 |
| TEEHAN BRENDAN Chief Operating Officer | -- | Direct | -- | May 1, 2024 |
| SCHNEYER MARK C. Chief Financial Officer | -- | Direct | -- | May 1, 2024 |
| DAVIS STEPHEN R Chief Executive Officer | Sale at price 17.87 per share. | Direct | 474,877 | Apr 8, 2024 |
| KIHARA JAMES Officer | Sale at price 17.87 per share. | Direct | 31,987 | Apr 8, 2024 |
| TEEHAN BRENDAN Chief Operating Officer | Sale at price 17.87 per share. | Direct | 45,890 | Apr 8, 2024 |
| SCHNEYER MARK C. Chief Financial Officer | Sale at price 17.87 per share. | Direct | 48,535 | Apr 8, 2024 |
| DAVIS STEPHEN R Chief Executive Officer | -- | Direct | -- | Apr 5, 2024 |
| KIHARA JAMES Officer | -- | Direct | -- | Apr 5, 2024 |
| TEEHAN BRENDAN Chief Operating Officer | -- | Direct | -- | Apr 5, 2024 |
Related Tickers
SRPT Sarepta Therapeutics, Inc.
54.42
-0.38%
APLS Apellis Pharmaceuticals, Inc.
18.97
-1.86%
BMRN BioMarin Pharmaceutical Inc.
60.02
+0.59%
INCY Incyte Corporation
58.46
-1.28%
IONS Ionis Pharmaceuticals, Inc.
28.38
-1.05%
NEU.AX Neuren Pharmaceuticals Limited
10.17
-7.38%
FOLD Amicus Therapeutics, Inc.
6.90
+2.68%
ALNY Alnylam Pharmaceuticals, Inc.
230.93
-3.78%
EXEL Exelixis, Inc.
36.54
+2.24%
AXSM Axsome Therapeutics, Inc.
103.83
+0.29%